BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6781042)

  • 1. Tubular proteinuria in myeloma.
    Ballocchi S; Bergonzi G; Dall'Aglio P; Fontana F; Gandi U; Pantano E; Poisetti P; Scarpioni L
    Ric Clin Lab; 1980; 10(1):149-56. PubMed ID: 6781042
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of free kappa and lambda light chains in urine by immunoenzyme analysis].
    León VJ; León E; Martínez-Pescador R; López-Borrasca A
    Sangre (Barc); 1986; 31(3):311-6. PubMed ID: 3092374
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoglobulin light-chain immunoblots of urine proteins from patients with tubular and Bence-Jones proteinuria.
    Norden AG; Fulcher LM; Flynn FV
    Clin Chim Acta; 1987 Jul; 166(2-3):307-15. PubMed ID: 3113774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple narrow bands in urine protein electrophoresis.
    Roach BM; Meinke JS; Sridhar N; Vladutiu AO
    Clin Chem; 1999 May; 45(5):716-8. PubMed ID: 10222367
    [No Abstract]   [Full Text] [Related]  

  • 5. Histology and function of the kidney in marked Bence Jones paraproteinuria.
    Nagengast FM; Assmann KJ; Fennis JF
    Neth J Med; 1980; 23(1):38. PubMed ID: 6767990
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary gamma-glutamyl transferase-to-creatinine ratio as an indicator of tubular function in Bence Jones proteinuria.
    Yesil EE; Paker N; Yesil A; Kayatas K; Laleli Y; Ari E
    Ren Fail; 2014 Apr; 36(3):390-2. PubMed ID: 24392854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bence-Jones myeloma. Clinical aspects, analysis and evolution].
    Sanchez de cos Escuin J; Moreno Norueira J; Carneado de la Fuente J
    Rev Clin Esp; 1978 Sep; 150(6):345-9. PubMed ID: 103147
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of Bence-Jones protein by isoelectric focussing of unconcentrated urine followed by nitrocellulose blotting and immunoperoxidase staining.
    Norden AG; Fulcher LM; Flynn FV
    Clin Chim Acta; 1985 Dec; 153(3):149-56. PubMed ID: 3935344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double Bence Jones proteinuria.
    Kanoh T; Yago K
    Arch Pathol Lab Med; 1990 Sep; 114(9):991-4. PubMed ID: 2117911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to therapy in IgG myeloma patients excreting lambda or kappa light chains: CALGB experience.
    Cornell CJ; McIntyre OR; Kochwa S; Weksler BB; Pajak TF
    Blood; 1979 Jul; 54(1):23-9. PubMed ID: 109133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic light-chain proteinuria: case report and review of the literature.
    Audard V; Damaj G; Rubio MT; Aucouturier P; Hermine O; Varet B
    Am J Hematol; 2004 Jul; 76(3):293-4. PubMed ID: 15224371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turbidimetric measurement of Bence-Jones proteins using antibodies against free light chains of immunoglobulins. An artifact caused by different polymeric forms of light chains.
    Heino J; Rajamäki A; Irjala K
    Scand J Clin Lab Invest; 1984 Apr; 44(2):173-6. PubMed ID: 6426036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria in multiple myeloma and related diseases.
    Ganeval D; Lacour B; Chopin N; Grünfeld JP
    Am J Nephrol; 1990; 10 Suppl 1():58-62. PubMed ID: 2124083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Light-chain myeloma and osteomalacia].
    Gardais J; Gardais B; Drouet M; Simard C; Perreau P
    Rev Rhum Mal Osteoartic; 1972 May; 39(5):386-95. PubMed ID: 4216070
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple myeloma with serum IgG kappa and Bence Jones lambda biclonal gammopathy.
    Finco B; Schiavon R
    Clin Chem; 1987 Jul; 33(7):1305-6. PubMed ID: 3109785
    [No Abstract]   [Full Text] [Related]  

  • 16. Ratio of urinary free immunoglobulin light chain kappa to lambda in the diagnosis of Bence Jones proteinuria.
    Nakano T; Nagata A; Takahashi H
    Clin Chem Lab Med; 2004 Apr; 42(4):429-34. PubMed ID: 15147154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.
    Stone MJ; Frendel EP
    Am J Med; 1975 May; 58(5):601-19. PubMed ID: 1130419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
    Levinson SS
    Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium dodecyl sulfate-agarose gel electrophoresis of urinary proteins: application to multiple myeloma.
    Le Bricon T; Erlich D; Bengoufa D; Dussaucy M; Garnier JP; Bousquet B
    Clin Chem; 1998 Jun; 44(6 Pt 1):1191-7. PubMed ID: 9625042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay of free light chains of immunoglobulins in urine.
    Robinson EL; Gowland E; Ward ID; Scarffe JH
    Clin Chem; 1982 Nov; 28(11):2254-8. PubMed ID: 6812991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.